Buy Stocks Easy | About Us

September 30, 2020

PRQR

Buy ProQR Therapeutics N.V. Stock (symbol: PRQR) Easy Online

Company Name: ProQR Therapeutics N.V.

Symbol: PRQR

Sector: Health Care

Industry: Major Pharmaceuticals

IPO: 2014

PRQR Current Share Price

Today's PRQR ( ProQR Therapeutics N.V. ) opening price: $9.8600

Yesterday's PRQR ( ProQR Therapeutics N.V. ) closing price: $9.8200

ProQR Therapeutics N.V. Stock ( symbol: PRQR ) Price Chart since IPO (2014):

12 Months ProQR Therapeutics N.V. Stock ( symbol: PRQR ) Price Chart

Popular Questions about ProQR Therapeutics N.V. Public Stock ( PRQR )

A: ProQR Therapeutics N.V. stock symbol (also called stock or share ticker) is PRQR

A: ProQR Therapeutics N.V. IPO (Initial Public Offering) took place on 2014

A: ProQR Therapeutics N.V.'s stock (PRQR symbol) price at ther IPO (initial Public Offering) was $9.8600

Q: Is PRQR stock worth buying at the moment?

A: The PRQR stock performance since 2019 are rather disappointing. If you had bought 1 share of ProQR Therapeutics N.V. stock (symbol: PRQR) at the beginning of 2019, at the opening share price of $15.7600, you would be left with exactly $9.8600 - which means a waste of your money and time. - SHOW ONLY IF equal or loose.

Buy ProQR Therapeutics N.V. Stock Easy Online

ProQR Therapeutics N.V. Stock Ticker Price Chart since IPO:

ProQR Therapeutics N.V. Stock Price Yesterday

ProQR Therapeutics N.V. Stock Price – Last Week

ProQR Therapeutics N.V. Stock Price – Last Month

ProQR Therapeutics N.V. Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

http://www.zacks.com/stock/news/667736/proqr-prqr-begins-dosing-in-phase-i-ii-eye-disorder-study

ProQR (PRQR) Begins Dosing in Phase I/II Eye Disorder Study

ProQR (PRQR) doses the first patient in the phase I/II Aurora study...

http://www.globenewswire.com/news-release/2019/12/11/1959121/0/en/ProQR-Announces-First-Patient-Dosed-in-Phase-1-2-Aurora-Trial-of-QR-1123-for-Autosomal-Dominant-Retinitis-Pigmentosa.html

ProQR Announces First Patient Dosed in Phase 1/2 Aurora Trial of QR-1123 for Autosomal Dominant Retinitis Pigmentosa

LEIDEN, Netherlands and CAMBRIDGE, Mass., Dec. 11, 2019 (GLOBE NE...

https://247wallst.com/healthcare-business/2019/11/21/proqr-therapeutics-takes-a-big-step-forward-with-its-latest-fda-approval/

ProQR Therapeutics Takes a Big Step Forward With Its Latest FDA Approval

ProQR Therapeutics N.V. (NASDAQ: PRQR) shares jumped early on Thurs...

https://www.marketwatch.com/story/proqr-shares-rises-on-fda-orphan-drug-designation-2019-11-21

ProQR shares rises on FDA orphan drug designation

Shares of ProQR Therapeutics rose 10% in premarket trading after i...

http://www.globenewswire.com/news-release/2019/11/21/1950669/0/en/ProQR-Receives-Orphan-Drug-Designation-from-FDA-for-QR-1123-for-Autosomal-Dominant-Retinitis-Pigmentosa.html

ProQR Receives Orphan Drug Designation from FDA for QR-1123 for Autosomal Dominant Retinitis Pigmentosa

LEIDEN, Netherlands and CAMBRIDGE, Mass., Nov. 21, 2019 (GLOBE NE...

http://www.zacks.com/stock/news/606265/proqr-prqr-reports-q3-loss-misses-revenue-estimates

ProQR (PRQR) Reports Q3 Loss, Misses Revenue Estimates

ProQR (PRQR) delivered earnings and revenue surprises of -9.38% and...

http://www.zacks.com/stock/news/578505/will-proqr-therapeutics-continue-to-surge-higher

Will ProQR Therapeutics Continue to Surge Higher?

As of late, it has definitely been a great time to be an investor P...

http://www.globenewswire.com/news-release/2019/10/18/1931831/0/en/ProQR-Announces-Closing-of-Underwritten-Public-Offering-of-Ordinary-Shares-with-Full-Exercise-of-Underwriters-Option-to-Purchase-Additional-Shares.html

ProQR Announces Closing of Underwritten Public Offering of Ordinary Shares with Full Exercise of Underwriters’ Option to Purchase Additional Shares

LEIDEN, the Netherlands and CAMBRIDGE, Mass., Oct. 18, 2019 (GLOB...

http://www.globenewswire.com/news-release/2019/10/16/1930239/0/en/ProQR-Prices-50-Million-Underwritten-Public-Offering-of-Ordinary-Shares.html

ProQR Prices $50 Million Underwritten Public Offering of Ordinary Shares

LEIDEN, The Netherlands and CAMBRIDGE, Mass., Oct. 15, 2019 (GLOB...

http://www.globenewswire.com/news-release/2019/10/15/1930119/0/en/ProQR-Announces-Proposed-Underwritten-Public-Offering-of-Ordinary-Shares.html

ProQR Announces Proposed Underwritten Public Offering of Ordinary Shares

LEIDEN, Netherlands and CAMBRIDGE, Mass., Oct. 15, 2019 (GLOBE NE...

All right reserved Buy Stocks Easy , 2019.